RESUMEN
Experiments on the isolated organs showed that ampicillin and levomycetin have pronounced D-antiserotoninergic effects; antagonism of antibodies and serotonin was found to be of competitive type. At an increase in levomycetin dosage D-antiserotoninergic effect was followed by the spasmolytic effect. Kefzol and benzylpenicillin failed to show any D-antiserotonin-ergic properties.
Asunto(s)
Antibacterianos/farmacología , Receptores de Serotonina/efectos de los fármacos , Antagonistas de la Serotonina/farmacología , Animales , Relación Dosis-Respuesta a Droga , Interacciones Farmacológicas , Femenino , Técnicas In Vitro , Ratas , Vejiga Urinaria/efectos de los fármacos , Útero/efectos de los fármacosAsunto(s)
Pielonefritis/etiología , Trastornos Urinarios/complicaciones , Animales , Niño , Perros , Femenino , Humanos , Masculino , UrodinámicaRESUMEN
In anesthetized dogs, intravenous administration of serotonin causes biphasic contraction of the urinary bladder followed by relaxation. The m-antagonist of serotonin, morphine inhibits the first phase of contraction but does not affect the second phase and relaxation. The T-antagonist tipindole exerts no effect on the serotonin-induced contraction and relaxation of the detrusor. The D-antagonists, LSD-25, dihydroergotamine, droperidol and cyproheptadine produce no effect on the first phase of contraction but inhibit the second one and successive relaxation of the urinary bladder detrusor. In addition to D-antagonists of serotonin, the relaxation of the detrusor is also suppressed by inderal and guanethidine which indicates the participation of the sympathetic component in the effect realization. The serotonin-induced relaxation of the detrusor is not suppressed by benzohexonium.
Asunto(s)
Músculo Liso/efectos de los fármacos , Antagonistas de la Serotonina/farmacología , Serotonina/farmacología , Vejiga Urinaria/efectos de los fármacos , Animales , Ciproheptadina/farmacología , Dihidroergotamina/farmacología , Perros , Droperidol/farmacología , Femenino , Guanetidina/farmacología , Compuestos de Hexametonio/farmacología , Indoles/farmacología , Dietilamida del Ácido Lisérgico/farmacología , Masculino , Morfina/farmacología , Propranolol/farmacologíaRESUMEN
Diarrhea that arises in mice given serotonin intravenously is not suppressed by tipindolol, LSD-25, ciproheptadine in doses in which these drugs block the D and T serotonin-reactive structures, or is not reduced by hexonium, thereby providing no evidence in favour of the reflex nature of the effect. Diarrhea is suppressed by morphine and atropine, thus pointing to the responsibility for its origin of M-serotoninoreactive structures of intestinal parasympathetic ganglia with subsequent involvement of the postganglionic cholinergic link.
Asunto(s)
Diarrea/inducido químicamente , Antagonistas de la Serotonina/uso terapéutico , Serotonina/envenenamiento , Animales , Atropina/uso terapéutico , Ciproheptadina/uso terapéutico , Diarrea/tratamiento farmacológico , Compuestos de Hexametonio , Indoles/uso terapéutico , Dietilamida del Ácido Lisérgico/uso terapéutico , Masculino , Ratones , Morfina/uso terapéuticoRESUMEN
Nonachlazin diminishes aseptic inflammation provoked by subplantar administration of carrageenin to rats. Nonachlazin increases the sensitivity pain threshold of the rat paw affected by carrageenin-induced inflammation, decreases the reaction of mice to intraperitoneal injection of phenylchinoin, and the ability of the rabbit central nervous system for impulse summation. Nonachlazin prevents carrageenin-induced temperature rise in rats.
Asunto(s)
Antiinflamatorios no Esteroideos , Nonaclazina/uso terapéutico , Fenotiazinas/uso terapéutico , Animales , Relación Dosis-Respuesta a Droga , Evaluación Preclínica de Medicamentos , Edema/tratamiento farmacológico , Fiebre/tratamiento farmacológico , Enfermedades del Pie/tratamiento farmacológico , Ratones , Dolor/fisiopatología , Ratas , Umbral Sensorial/efectos de los fármacosRESUMEN
Droperidol, haloperidol and azabutyron inhibit the reactions of rabbit aortal stria caused by stimulation of D-type serotonine receptors. Droperidol appears most active in this respect. Its antiserotonine properties are characterised by certain selectivity. The capacity of droperidol for protection of D-receptors against irreversible dibenamine blockade suggests its indirect interaction with D-receptors.
Asunto(s)
Antipsicóticos/farmacología , Receptores de Serotonina/efectos de los fármacos , Animales , Aorta Torácica/efectos de los fármacos , Butirofenonas , Antagonismo de Drogas , Femenino , Técnicas In Vitro , Conejos , Ratas , Serotonina/farmacología , Antagonistas de la Serotonina , Útero/efectos de los fármacosAsunto(s)
Antidepresivos Tricíclicos/farmacología , Imipramina/farmacología , Fenotiazinas/farmacología , Antagonistas de la Serotonina , Fibras Adrenérgicas/metabolismo , Animales , Histocitoquímica , Técnicas In Vitro , Masculino , Norepinefrina/metabolismo , Ratas , Vesículas Sinápticas/metabolismo , Conducto Deferente/inervación , Conducto Deferente/metabolismoRESUMEN
Contractions of the isolated rat vas deferens in response to the addition of serotonin could be explained by the release of catecholamines from the nerve endings. As shown by the use of D-, M- and T-antagonists of serotonin (LSD-25, indocarb, typindole), symatholytic--bretilium, alpha-adrenolytic--droperidol and imipramine, this effect was not associated with the direct activation of serotonin- and adrenoreactive receptors.